Target intelligence / Profile preview

Guanine nucleotide-binding protein G(t) subunit alpha-1 (GNAT1)

Target
GNAT1
Molecular classification
G protein alpha subunit, signal transducer, heterotrimeric G-protein, GTPase
01

Overview

Guanine nucleotide-binding protein G(t) subunit alpha-1 (GNAT1) is the rod-specific alpha subunit of the heterotrimeric G protein complex known as transducin, which is found in retinal rod photoreceptor cells. It plays a central role in the phototransduction cascade, coupling the activation of rhodopsin by light to downstream effectors that generate electrical signals, ultimately enabling vision in low-light conditions. When activated by rhodopsin, GNAT1 promotes GTP binding, dissociates from the G protein complex, and activates cGMP-phosphodiesterase (cGMP-PDE), initiating signal transduction processes necessary for vision. Mutations in this gene can cause autosomal dominant congenital stationary night blindness due to disruption of this signaling pathway[1][2][3][6]. GNAT1 is not presently known to be a direct pharmacological drug target, being primarily studied for its fundamental role in vision and as a genetic cause of retinal diseases rather than as a tractable therapeutic target.

Other names
GNATRTransducin alpha-1 chainCSNBAD3GBT1GNAT1_HUMANguanine nucleotide binding protein (G protein), alpha transducing activity polypeptide 1guanine nucleotide-binding protein G(T), alpha-1 subunitrod-type transducin alpha subunittransducin, rod-specific
02

Biological functions

Signal transductionVisual perceptionPhototransductionDetection of light stimulus
03

Disease associations

Neurodegenerative disease (congenital stationary night blindness)
04

Safety considerations

No notable broader therapeutic safety concerns reported; loss or dysfunction leads specifically to visual processing defects such as night blindness
05

Biomarkers

Mutations are linked to congenital stationary night blindness and may serve as diagnostic biomarkers

Beyond the preview

Go deeper on Guanine nucleotide-binding protein G(t) subunit alpha-1 (GNAT1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Guanine nucleotide-binding protein G(t) subunit alpha-1 (GNAT1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call